Jacobs Levy Equity Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.39M | Sell |
1,205,128
-374,227
| -24% | -$1.36M | 0.02% | 463 |
|
|
2025
Q1 | $3.03M | Buy |
1,579,355
+350,645
| +29% | +$673K | 0.01% | 568 |
|
|
2024
Q4 | $2.33M | Sell |
1,228,710
-805,459
| -40% | -$1.53M | 0.01% | 568 |
|
|
2024
Q3 | $2.69M | Sell |
2,034,169
-60,564
| -3% | -$79.9K | 0.01% | 546 |
|
|
2024
Q2 | $2.14M | Buy |
2,094,733
+457,155
| +28% | +$466K | 0.01% | 587 |
|
|
2024
Q1 | $3M | Sell |
1,637,578
-219,347
| -12% | -$401K | 0.01% | 525 |
|
|
2023
Q4 | $2.3M | Buy |
1,856,925
+137,864
| +8% | +$171K | 0.01% | 579 |
|
|
2023
Q3 | $1.96M | Buy |
1,719,061
+373,029
| +28% | +$425K | 0.01% | 556 |
|
|
2023
Q2 | $1.23M | Buy |
1,346,032
+147,308
| +12% | +$135K | 0.01% | 659 |
|
|
2023
Q1 | $672K | Sell |
1,198,724
-816,043
| -41% | -$457K | ﹤0.01% | 763 |
|
|
2022
Q4 | $1.16M | Sell |
2,014,767
-28,049
| -1% | -$16.2K | 0.01% | 658 |
|
|
2022
Q3 | $646K | Buy |
2,042,816
+1,265,199
| +163% | +$400K | 0.01% | 792 |
|
|
2022
Q2 | $275K | Sell |
777,617
-207,124
| -21% | -$73.2K | ﹤0.01% | 936 |
|
|
2022
Q1 | $707K | Sell |
984,741
-1,753,159
| -64% | -$1.26M | ﹤0.01% | 811 |
|
|
2021
Q4 | $6.19M | Buy |
2,737,900
+75,855
| +3% | +$171K | 0.04% | 389 |
|
|
2021
Q3 | $7.67M | Sell |
2,662,045
-245,289
| -8% | -$706K | 0.05% | 354 |
|
|
2021
Q2 | $11M | Buy |
2,907,334
+239,305
| +9% | +$907K | 0.07% | 274 |
|
|
2021
Q1 | $9.03M | Buy |
2,668,029
+673,177
| +34% | +$2.28M | 0.07% | 305 |
|
|
2020
Q4 | $5.59M | Buy |
1,994,852
+1,296,947
| +186% | +$3.63M | 0.05% | 375 |
|
|
2020
Q3 | $1.75M | Buy |
697,905
+230,762
| +49% | +$579K | 0.02% | 541 |
|
|
2020
Q2 | $6.34M | Sell |
467,143
-30,615
| -6% | -$416K | 0.07% | 298 |
|
|
2020
Q1 | $3.77M | Buy |
497,758
+136,125
| +38% | +$1.03M | 0.05% | 349 |
|
|
2019
Q4 | $2.29M | Buy |
+361,633
| New | +$2.29M | 0.02% | 520 |
|
|
2019
Q3 | – | Sell |
-152,461
| Closed | -$738K | – | 912 |
|
|
2019
Q2 | $738K | Sell |
152,461
-485,099
| -76% | -$2.35M | 0.01% | 685 |
|
|
2019
Q1 | $5.22M | Buy |
637,560
+222,708
| +54% | +$1.82M | 0.08% | 324 |
|
|
2018
Q4 | $2.29M | Buy |
414,852
+84,400
| +26% | +$467K | 0.04% | 431 |
|
|
2018
Q3 | $2.92M | Buy |
330,452
+54,299
| +20% | +$479K | 0.04% | 432 |
|
|
2018
Q2 | $2.76M | Buy |
276,153
+192,834
| +231% | +$1.92M | 0.04% | 435 |
|
|
2018
Q1 | $794K | Buy |
83,319
+46,909
| +129% | +$447K | 0.01% | 686 |
|
|
2017
Q4 | $541K | Buy |
36,410
+14,620
| +67% | +$217K | 0.01% | 737 |
|
|
2017
Q3 | $429K | Buy |
21,790
+2,310
| +12% | +$45.5K | 0.01% | 730 |
|
|
2017
Q2 | $280K | Buy |
+19,480
| New | +$280K | 0.01% | 781 |
|
|
2016
Q3 | – | Sell |
-16,465
| Closed | -$123K | – | 1006 |
|
|
2016
Q2 | $123K | Buy |
+16,465
| New | +$123K | ﹤0.01% | 1073 |
|